NIGHTINGALE Financial Statements From 2010 to 2024
| 7XE Stock | EUR 2.95 0.10 3.28% |
Check NIGHTINGALE HEALTH financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NIGHTINGALE HEALTH's main balance sheet or income statement drivers, such as , as well as many indicators such as . NIGHTINGALE financial statements analysis is a perfect complement when working with NIGHTINGALE HEALTH Valuation or Volatility modules.
NIGHTINGALE |
NIGHTINGALE HEALTH EO Company Shares Owned By Insiders Analysis
NIGHTINGALE HEALTH's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current NIGHTINGALE HEALTH Shares Owned By Insiders | 50.45 % |
Most of NIGHTINGALE HEALTH's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NIGHTINGALE HEALTH EO is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 50% of NIGHTINGALE HEALTH EO are shares owned by insiders. This is 232.35% higher than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The shares owned by insiders for all Germany stocks is notably lower than that of the firm.
NIGHTINGALE HEALTH Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NIGHTINGALE HEALTH's current stock value. Our valuation model uses many indicators to compare NIGHTINGALE HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NIGHTINGALE HEALTH competition to find correlations between indicators driving NIGHTINGALE HEALTH's intrinsic value. More Info.NIGHTINGALE HEALTH EO is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NIGHTINGALE HEALTH's earnings, one of the primary drivers of an investment's value.About NIGHTINGALE HEALTH Financial Statements
NIGHTINGALE HEALTH stakeholders use historical fundamental indicators, such as NIGHTINGALE HEALTH's revenue or net income, to determine how well the company is positioned to perform in the future. Although NIGHTINGALE HEALTH investors may analyze each financial statement separately, they are all interrelated. For example, changes in NIGHTINGALE HEALTH's assets and liabilities are reflected in the revenues and expenses on NIGHTINGALE HEALTH's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in NIGHTINGALE HEALTH EO. Please read more on our technical analysis and fundamental analysis pages.
Nightingale Health Ltd. offers a health data platform that detects disease risks. The company was founded in 2002 and is based in Helsinki, Finland. NIGHTINGALE HEALTH is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in NIGHTINGALE Stock
NIGHTINGALE HEALTH financial ratios help investors to determine whether NIGHTINGALE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NIGHTINGALE with respect to the benefits of owning NIGHTINGALE HEALTH security.